Global Medical Cyclotron Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Medical Cyclotron Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

A Medical Cyclotron is a particle accelerator that repeatedly propels a beam of charged particles (protons) in a circular path. Medical radioisotopes are made from non-radioactive materials (stable isotopes) that are bombarded with these protons. When a beam of protons interacts with a stable isotope, a nuclear reaction occurs, turning the stable isotope into a radioactive isotope. They are used on the one hand for radiation therapy (simultaneous delivery of ion beams and neutrons) and on the other hand for the production of radiotracers for diagnostics by emission tomography and for internal radiation therapy. Helping doctors and researchers diagnose, observe and treat diseases such as cancer. Helping doctors and researchers diagnose, observe and treat diseases such as cancer.

Market Overview:

The latest research study on the global Medical Cyclotron market finds that the global Medical Cyclotron market reached a value of USD 201.51 million in 2022. It’s expected that the market will achieve USD 330.59 million by 2028, exhibiting a CAGR of 8.6% during the forecast period.

The COVID-19 pandemic has had a huge impact on the global economy, the environment and most human activities. The epidemic has had a great impact on the industrial chain of Medical Cyclotron. Lockdowns or quarantines in many countries to control the spread of the coronavirus have hit logistics hard, disrupting supply chains for many businesses. The upstream company affects the work progress of the downstream company. The insufficient supply of raw materials leads to the inability to deliver orders in time, the production plan is seriously hindered, and the company's production capacity is forced to reduce.

Compared with traditional radiotherapy, proton radiotherapy can achieve fixed-point blasting of tumors, with higher accuracy, while avoiding damage to normal tissues and reducing side effects and complications. It is considered to be the most advanced and more advanced in the world. Precise and cutting-edge radiation therapy technology. Precise radiotherapy for tumors with proton beams has the advantages of good dose distribution, high local dose, and less side scatter. Superconducting magnets are the core components of superconducting cyclotrons.

Since medical devices directly affect the human body and are directly related to human life and health, they have always been the focus of monitoring by governments around the world. In addition, for the sake of protecting their own enterprises, each country has a set of rules and regulations for market entry. For medical cyclotron equipment, its components also need to be managed as medical devices and subject to strict standard control; the whole system needs to obtain a Class III medical device registration certificate before it can be produced and sold.

In recent years, many emerging and traditional industries have embarked on digital transformation. Therefore, this will also become a major trend in the subsequent development of enterprises.

Region Overview:

In 2021, the share of the Medical Cyclotron market in Europe stood at 34.97%.

Company Overview:

IBA

Founded in 1986, IBA is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. IBA is the world leader for the supply of PET & SPECT cyclotrons for radiopharmaceuticals production. Headquartered in Belgium, IBA installed and supports over 300 cyclotrons across the world.

GE

General Electric Company (GE) is an American multinational conglomerate founded in 1892, and incorporated in New York state and headquartered in Boston. The company operated in sectors including healthcare, aviation, power, renewable energy, digital industry, additive manufacturing and venture capital and finance, but has since divested from several areas. GE HealthCare is a manufacturer and distributor of diagnostic imaging agents and radiopharmaceuticals for imaging modalities used in medical imaging procedures. It offers dyes used in magnetic-resonance-imaging procedures; manufactures medical diagnostic equipment, including CT image machines; MRI, XRAY; Ultrasound; Cath Labs; Mamogram; Nuclear Medicine Cameres; and develops Health technology for medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery, and biopharmaceutical manufacturing.

IBA is one of the major players operating in the Medical Cyclotron market, holding a share of 41.51%
in 2022.

Segmentation Overview:

According to the energy of electron beams, medical cyclotrons can be divided into low-energy medical cyclotrons and high-energy medical cyclotrons. Low-energy medical cyclotron means that the proton energy is lower than 19mev, and when the proton energy is higher than 19mev, it is defined as a medical cyclotron. Different sizes of energy can be adapted to the treatment of tumors with different depths, and its application range gradually extends from deep tumors to superficial tumors.

Application Overview:

Cyclotrons are growing rapidly and playing an increasingly important role in healthcare, especially in advanced medical imaging procedures, as cyclotron-produced radiopharmaceuticals are highly effective in detecting various cancers, enabling small and medium-sized hospitals to produce their own in-house radiopharmaceutical products, while providing wider global access to diagnostic solutions in oncology, neurology and cardiology.

The cyclotron is capable of producing radiotracers to support positron emission tomography (PET) research in the fields of neurology, oncology and cardiology, among others.

Key Companies in the global Medical Cyclotron market covered in Chapter 3:

IBA
Sumitomo
ACSI
Siemens
GE
Best Medical

In Chapter 4 and Chapter 14.2, on the basis of types, the Medical Cyclotron market from 2018 to 2029 is primarily split into:

Low Energy Medical Cyclotron
High Energy Medical Cyclotron

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Medical Cyclotron market from 2018 to 2029 covers:

Commercial
Academic

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)